Yan Zhou

TL;DR: This study identified demographic, clinical, and hospital-level risk factors that may be associated with death in critically ill patients with COVID-19 and can facilitate the identification of medications and supportive therapies to improve outcomes.

TL;DR: Among critically ill patients with COVID-19 in this cohort study, the risk of in-hospital mortality in this study was lower in patients treated with tocilizumab in the first 2 days of ICU admission compared with patients whose treatment did not include early use of tocilzumab, and the findings may be susceptible to unmeasured confounding.

TL;DR: Uterine leiomyomas supplied by both uterine arteries and with rich blood flow were seen in approximately 50 % of patients, however, close attention also should be given to the collateral circulation during UAE.

TL;DR: Prior BBs use was independently associated with increased inpatient mortality, and should be considered a high risk marker for patients presenting with acute myocardial infarction.

TL;DR: In this article, the authors tested the performance of crisis standards of care (CSC) guidelines for allocating scarce critical care resources during the COVID-19 pandemic and found that the algorithm incorporating comorbidities has modestly worse predictive performance for Black compared to white patients.